Improving infection control in nursing homes: Enhanced barrier precautions and multidrug-resistant organism colonization.

Am J Infect ControlJun 18, 2026 (epub)

Mary-Claire Roghmann, Lyndsay M O'Hara, Stephanie Mayoryk et al.

✦ AI-curated · Sources linked

In 30 seconds

This multicenter clinical trial evaluated the effectiveness of enhanced barrier precautions (EBP) in identifying multidrug-resistant organism (MDRO) colonization among 580 short-stay nursing home residents. The study found that only 21% of residents were culture-positive for MDROs, despite 31% having EBP indications. Notably, MDRO history was a poor predictor of current colonization status.

Key findings

  • 21% of residents were culture-positive for MDROs.
  • 31% of residents had one or more EBP indications.
  • Only 25% of residents with MDRO history were culture-positive.
  • Novel or targeted MDROs were rare among the population.

Why it matters

Understanding the prevalence and identification of MDRO colonization in nursing homes is crucial for infection control. This study highlights the limitations of relying solely on MDRO history for implementing enhanced precautions, which may impact patient safety and resource allocation.

Source

Published in Am J Infect Control. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.